Medical Xpress July 25, 2024
Weill Cornell Medical

Two Medicaid policies can interact to increase oncology clinical trial enrollment among Black and Hispanic patients, according to a new study by investigators at Weill Cornell Medicine, the University of Pennsylvania, and Medidata AI. Black and Hispanic patients are historically underrepresented in cancer clinical trials; equitable enrollment helps ensure the knowledge gained from trials generalizes to the entire population and promotes equitable patient access to the latest treatment options.

The study, published July 25 in the Journal of Clinical Oncology, examined the effect of the interaction between two Medicaid policies on the rates of enrollment for Black or Hispanic adults in cancer clinical trials in the United States: Medicaid expansion under the Affordable Care Act (ACA), which extended Medicaid eligibility...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Insurance, Medicaid, Trends
Redesigning Integrated Care For Dually Eligible People With Intellectual/Developmental Disabilities
Medicaid spending on weight loss, diabetes drugs up 500% since 2019: 5 numbers to know
CMS Launches New Program for Mental Health, OUD Treatment
Georgia Medicaid shakeup could force 3 in 4 beneficiaries to change plans: Centene CEO
New Center to Coordinate Between Medicaid, Maternal and Child Health

Share This Article